Cognitive Performance Among Carriers of Pathogenic Copy Number Variants: Analysis of 152,000 UK Biobank Subjects

Biological Psychiatry

Volumn 82, Issue 2, 2017, Pages 103-110

  Kendall, Kimberley M ^a   Rees, Elliott ^a   Escott Price, Valentina ^a   Einon, Mark ^a   Thomas, Rhys ^a   Hewitt, Jonathan ^b   O'Donovan, Michael C ^a   Owen, Michael J ^a   Walters, James T R ^a   Kirov, George ^a  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b LLANDOUGH HOSPITAL   (United Kingdom)

Author keywords

Affymetrix; CNV; Cognition; Neurodevelopmental; Schizophrenia; UK Biobank

Indexed keywords

ADULT; AGED; ARTICLE; BIOBANK; CONTROLLED STUDY; COPY NUMBER VARIATION; EDUCATIONAL STATUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL CAPACITY; MENTAL PERFORMANCE; NERVE CELL DIFFERENTIATION; PRIORITY JOURNAL; SCHIZOPHRENIA; UNITED KINGDOM; COGNITIVE DEFECT; GENETICS; MENTAL DISEASE; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; BIOLOGICAL SPECIMEN BANKS; COGNITIVE DYSFUNCTION; DNA COPY NUMBER VARIATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURODEVELOPMENTAL DISORDERS; NEUROPSYCHOLOGICAL TESTS; SCHIZOPHRENIA; UNITED KINGDOM;

EID: 85005947800     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2016.08.014     Document Type: Article

References (32)

1. Lee, C., Scherer, S.W., The clinical context of copy number variation in the human genome. Expert Rev Mol Med, 12, 2010, e8.
2. Feuk, L., Carson, A.R., Scherer, S.W., Structural variation in the human genome. Nat Rev Genet 7 (2006), 85–97.
3. Shaffer, L.G., Lupski, J.R., Molecular mechanisms for constitutional chromosomal rearrangements in humans. Annu Rev Genet 34 (2000), 297–329.
4. Coe, B.P., Witherspoon, K., Rosenfeld, J.A., van Bon, B.W., Vulto-van Silfhout, A.T., Bosco, P., et al. Refining analyses of copy number variation identifies specific genes associated with developmental delay. Nat Genet 46 (2014), 1063–1071.
5. Dittwald, P., Gambin, T., Szafranski, P., Li, J., Amato, S., Divon, M.Y., et al. NAHR-mediated copy-number variants in a clinical population: Mechanistic insights into both genomic disorders and Mendelizing traits. Genome Res 23 (2013), 1395–1409.
6. Lal, D., Ruppert, A.K., Trucks, H., Schulz, H., de Kovel, C.G., Kasteleijn-Nolst Trenitû̀, D., et al. Burden analysis of rare microdeletions suggests a strong impact of neurodevelopmental genes in genetic generalised epilepsies. PLoS Genet, 11, 2015, e1005226.
7. Rees, E., Walters, J.T., Georgieva, L., Isles, A.R., Chambert, K.D., Richards, A.L., et al. Analysis of copy number variations at 15 schizophrenia-associated loci. Br J Psychiatry 204 (2014), 108–114.
8. Rees, E., Kendall, K., Pardiñas, A., Legge, S., Pocklington, A., Escott-Price, A., et al. Analysis of intellectual disability copy number variants for association with schizophrenia. JAMA Psychiatry 73 (2016), 963–969.
9. Kirov, G., Rees, E., Walters, J.T., Escott-Price, V., Georgieva, L., Richards, A.L., et al. The penetrance of copy number variations for schizophrenia and developmental delay. Biol Psychiatry 75 (2014), 378–385.
10. Stefansson, H., Meyer-Lindenberg, A., Steinberg, S., Magnusdottir, B., Morgen, K., Arnarsdottir, S., et al. CNVs conferring risk of autism or schizophrenia affect cognition in controls. Nature 505 (2014), 361–366.
11. MûÊnnik, K., MûÊgi, R., Macû̀, A., Cole, B., Guyatt, A.L., Shihab, H.A., et al. Copy number variations and cognitive phenotypes in unselected populations. JAMA 313 (2015), 2044–2054.
12. Wain, L.V., Shrine, N., Miller, S., Jackson, V.E., Ntalla, I., Soler Artigas, M., et al. Novel insights into the genetics of smoking behaviour, lung function, and chronic obstructive pulmonary disease (UK BiLEVE): A genetic association study in UK Biobank. Lancet Respir Med 3 (2015), 769–781.
13. Rees, E., Walters, J.T., Chambert, K.D., O'Dushlaine, C., Szatkiewicz, J., Richards, A.L., et al. CNV analysis in a large schizophrenia sample implicates deletions at 16p12.1 and SLC1A1 and duplications at 1p36.33 and CGNL1. Hum Mol Genet 23 (2014), 1669–1676.
14. Kirov, G., Pocklington, A.J., Holmans, P., Ivanov, D., Ikeda, M., Ruderfer, D., et al. De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol Psychiatry 17 (2012), 142–153.
15. Ikeda, M., Aleksic, B., Kirov, G., Kinoshita, Y., Yamanouchi, Y., Kitajima, T., et al. Copy number variation in schizophrenia in the Japanese population. Biol Psychiatry 67 (2010), 283–286.
16. Grozeva, D., Kirov, G., Conrad, D.F., Barnes, C.P., Hurles, M., Owen, M.J., et al. Reduced burden of very large and rare CNVs in bipolar affective disorder. Bipolar Disord 15 (2013), 893–898.
17. Wang, K., Li, M., Hadley, D., Liu, R., Glessner, J., Grant, S.F., et al. PennCNV: An integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Res 17 (2007), 1665–1674.
18. Levinson, D.F., Duan, J., Oh, S., Wang, K., Sanders, A.R., Shi, J., et al. Copy number variants in schizophrenia: Confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications. Am J Psychiatry 168 (2011), 302–316.
19. International Schizophrenia Consortium. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 455 (2008), 237–241.
20. Wagner, R., Intelligence, training and employment. Am Psychologist 52 (1997), 1059–1069.
21. Schmidt, F., The role of general cognitive ability and job performance: Why there cannot be a debate. Hum Performance 15 (2002), 187–210.
22. Office for National Statistics. Standard Occupational Classification 2000. 2000, The Stationery Office, London.
23. Kirov, G., CNVs in neuropsychiatric disorders. Hum Mol Genet 24 (2015), R45–R49.
24. Strenze, T., Intelligence and socioeconomic success: A meta-analytic review of longitudinal research. Intelligence 35 (2007), 401–426.
25. Moreno-De-Luca, A., Myers, S.M., Challman, T.D., Moreno-De-Luca, D., Evans, D.W., Ledbetter, D.H., Developmental brain dysfunction: Revival and expansion of old concepts based on new genetic evidence. Lancet Neurol 12 (2013), 406–414.
26. McGrath, J., Saha, S., Chant, D., Welham, J., Schizophrenia: A concise overview of incidence, prevalence, and mortality. Epidemiol Rev 30 (2008), 67–76.
27. Collins, R., What makes UK Biobank special?. Lancet 379 (2012), 1173–1174.
28. Manolio, T.A., Collins, R., Enhancing the feasibility of large cohort studies. JAMA 304 (2010), 2290–2291.
29. McCarthy, S.E., Makarov, V., Kirov, G., Addington, A.M., McClellan, J., Yoon, S., et al. Microduplications of 16p11.2 are associated with schizophrenia. Nat Genet 41 (2009), 1223–1227.
30. Jacquemont, S., Reymond, A., Zufferey, F., Harewood, L., Walters, R.G., Kutalik, Z., et al. Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locus. Nature 478 (2011), 97–102.
31. Chance, P.F., Abbas, N., Lensch, M.W., Pentao, L., Roa, B.B., Patel, P.I., et al. Two autosomal dominant neuropathies result from reciprocal DNA duplication/deletion of a region on chromosome 17. Hum Mol Genet 3 (1994), 223–228.
32. Lupski, J.R., Wise, C.A., Kuwano, A., Pentao, L., Parke, J.T., Glaze, D.G., et al. Gene dosage is a mechanism for Charcot-Marie-Tooth disease type 1A. Nat Genet 1 (1992), 29–33.